Abstract |
Cyclic GMP is a ubiquitous second messenger that regulates a wide array of physiologic processes such as blood pressure, long bone growth, intestinal fluid secretion, phototransduction and lipolysis. Soluble and single-membrane-spanning enzymes called guanylyl cyclases (GC) synthesize cGMP. In humans, the latter group consists of GC-A, GC-B, GC-C, GC-E and GC-F, which are also known as NPR-A, NPR-B, StaR, Ret1-GC and Ret2-GC, respectively. Membrane GCs are activated by peptide ligands such as atrial natriuretic peptide ( ANP), B-type natriuretic peptide (BNP), C-type natriuretic peptide (CNP), guanylin, uroguanylin, heat stable enterotoxin and GC-activating proteins. Nesiritide and carperitide are clinically approved peptide-based drugs that activate GC-A. CD-NP is an experimental heart failure drug that primarily activates GC-B but also activates GC-A at high concentrations and is resistant to degradation. Inactivating mutations in GC-B cause acromesomelic dysplasia type Maroteaux dwarfism and chromosomal mutations that increase CNP concentrations are associated with Marfanoid-like skeletal overgrowth. Pump-based CNP infusions increase skeletal growth in a mouse model of the most common type of human dwarfism, which supports CNP/GC-B-based therapies for short stature diseases. Linaclotide is a peptide activator of GC-C that stimulates intestinal motility and is in late-stage clinical trials for the treatment of chronic constipation. This review discusses the discovery of cGMP, guanylyl cyclases, the general characteristics and therapeutic applications of GC-A, GC-B and GC-C, and emphasizes the regulation of transmembrane guanylyl cyclases by phosphorylation and ATP.
|
Authors | Lincoln R Potter |
Journal | Pharmacology & therapeutics
(Pharmacol Ther)
Vol. 130
Issue 1
Pg. 71-82
(Apr 2011)
ISSN: 1879-016X [Electronic] England |
PMID | 21185863
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
|
Copyright | Copyright © 2010. Published by Elsevier Inc. |
Chemical References |
- Receptors, Cell Surface
- Receptors, Peptide
- guanyl cyclase-B receptor
- Atrial Natriuretic Factor
- Cyclic AMP
- Guanylate Cyclase
- Receptors, Atrial Natriuretic Factor
- Receptors, Enterotoxin
- Receptors, Guanylate Cyclase-Coupled
- atrial natriuretic factor receptor A
- Cyclic GMP
|
Topics |
- Animals
- Atrial Natriuretic Factor
(metabolism)
- Blood Pressure
(drug effects)
- Bone Development
- Cyclic AMP
(metabolism)
- Cyclic GMP
(metabolism)
- Disease Models, Animal
- Guanylate Cyclase
(chemistry, metabolism)
- Heart Failure
(drug therapy, physiopathology)
- Humans
- Mice
- Molecular Targeted Therapy
- Receptors, Atrial Natriuretic Factor
(metabolism)
- Receptors, Cell Surface
(metabolism)
- Receptors, Enterotoxin
- Receptors, Guanylate Cyclase-Coupled
(metabolism)
- Receptors, Peptide
(metabolism)
|